Drugs.com - FDA MedWatch Alerts

Amneal Pharmaceutical LLC Issues a Nationwide Recall of Sulfamethoxazole / Trimethoprim Tablets, USP, 400 mg/80 mg Only, Due to Microbial Contamination

Audience: Consumer, Pharmacy, Health Care Professional June 02, 2025 -- Amneal Pharmaceutical LLC, is recalling three lots of Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg to the consumer level as the tablets may exhibit black spots on...

Jun 5, 2025 - 01:35
 0
Amneal Pharmaceutical LLC Issues a Nationwide Recall of Sulfamethoxazole / Trimethoprim Tablets, USP, 400 mg/80 mg Only, Due to Microbial Contamination
Audience: Consumer, Pharmacy, Health Care Professional June 02, 2025 -- Amneal Pharmaceutical LLC, is recalling three lots of Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg to the consumer level as the tablets may exhibit black spots on...
Read More

Tags:

Previous Article

Cellectar Granted U.S. FDA Breakthrough Therapy Designation for Iopofosine I 131...

Next Article

U.S. FDA Approves Third Indication of Nubeqa (darolutamide) for Patients with Ad...

Related Posts

Voluntary Lot Withdrawals of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) Due to Increased Reports of Allergic/Hypersensitivity Reactions

Voluntary Lot Withdrawals of Immune Globulin Intravenou...

May 12, 2025  0

Gilead Issues Voluntary Nationwide Recall of One Lot of Veklury (Remdesivir) for Injection 100 mg/vial Due to the Presence of a Glass Particle

Gilead Issues Voluntary Nationwide Recall of One Lot of...

May 12, 2025  0

FDA Warns Health Care Professionals Not to Use Epinephrine Nasal Solutions from BPI Labs and Endo USA

FDA Warns Health Care Professionals Not to Use Epinephr...

May 12, 2025  0